시장보고서
상품코드
1888586

경성 내시경 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 시야각별, 제품 치수별, 제품 길이별, 외과 센터 규모별, 외과 센터 소재지별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Rigid Endoscopes Market Size, Share & Trends Analysis Report By Product, By Angle of View, By Product Dimension, By Product Length, By Surgical Center Size, By Surgical Center Location, By End-use, By Region, And Segment Forecasts, 2025 - 2033

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

경성 내시경 시장 요약

세계의 경성 내시경 시장 규모는 2024년에 73억 1,000만 달러로 추정되며, 2033년까지 111억 1,000만 달러에 달할 것으로 예측됩니다.

2025-2033년 CAGR 4.74%로 성장할 것으로 예상됩니다. 전 세계적으로 암 및 암 관련 사망률의 증가 추세는 시장을 견인하는 요인 중 하나가 될 것으로 예상됩니다.

예를 들어, 미국 암협회가 발표한 '2023 암 진행 보고서'에 따르면, 2023년 미국에서 약 195만 8,310건의 신규 암이 진단되고, 60만 9,820명이 암으로 사망할 것으로 예상했습니다. 예측에 따르면, 2040년까지 신규 암 발병 건수는 230만 건에 달할 것으로 보입니다. 전 세계적으로 암의 유병률이 증가함에 따라 효과적인 진단 및 치료 절차에 대한 요구가 증가하고 있습니다. 내시경은 다양한 형태의 암을 정확하게 진단, 병기 및 치료할 수 있는 최소침습적 치료 옵션을 제공하는 데 중요한 역할을 하고 있습니다.

또한, 내시경 초음파 검사(EUS), 내시경적 역행성 담관 췌담관 조영술(ERCP) 등의 내시경 검사는 소화관, 폐, 기타 부위의 암을 발견하고 평가하는 데 유용합니다. 이 검사를 통해 개복 수술 없이 체내 조직을 정밀하게 관찰하고, 생검을 채취하며, 전암 병변이나 조기 종양을 제거할 수 있습니다. 이를 통해 환자의 예후를 개선하고 침습적 수술에 따른 회복 기간과 합병증 위험을 크게 줄일 수 있습니다.

최소침습수술(키홀수술)은 작은 절개를 통해 다양한 질환을 진단하고 치료하는 수술로, 세계적으로 널리 인정받고 있습니다. 외과 의사들은 기존의 개복 수술에 비해 로봇 보조 수술과 내시경 수술이 제공하는 여러 가지 장점으로 인해 점점 더 선호하는 경향이 있습니다.

최소침습수술의 장점

  • 수술 후 합병증 감소 : 최소침습 수술은 기존 개복 수술에 비해 수술 후 합병증 위험을 크게 줄입니다. 작은 절개는 감염 및 기타 수술 합병증의 가능성을 줄여줍니다.
  • 입원기간 및 회복기간 단축 : 최소침습수술을 받은 환자는 일반적으로 입원기간이 짧고 회복이 빠른 경향이 있습니다. 이를 통해 환자의 편의성이 향상되고, 의료 시설의 부담을 줄일 수 있습니다.
  • 출혈량 감소 : 이러한 수술은 수술 중 출혈량이 적어 환자의 안전과 회복에 매우 중요합니다.
  • 경제성 : 최소침습 수술은 개복 수술보다 비용 효율성이 높은 경우가 많습니다. 입원 기간 단축과 빠른 회복으로 전체 의료비를 절감하여 경제적으로 실현 가능한 대안이 될 수 있습니다.

경성 내시경 시장에서는 FDA 승인 건수의 대폭적인 증가와 신제품의 잇따른 출시가 확인되고 있습니다. 이는 의료기술의 발전과 최소침습수술에 대한 수요 증가에 기인합니다. 또한, 영상기술의 혁신이 신제품 출시의 흐름을 주도하여 진단 및 치료 시술의 정확성과 유효성을 높이고 있습니다. 신제품 출시로 의료진의 선택의 폭이 넓어지고, 환자의 치료 성과가 향상되며, 시장 내 경쟁이 활성화되고 있습니다. 따라서 각 제조사들은 빠르게 변화하는 환경에서 우위를 유지하기 위해 연구개발(R&D)을 강화하고 있습니다.

이러한 발전은 FDA 승인 건수 및 제품 출시의 증가로 환자 안전이 향상되고 시장 성장을 견인하는 등 시장의 중요한 변화를 보여줍니다. 병원, 종양전문클리닉, 암센터 등 의료시설의 증가에 따라 경성내시경의 수요가 증가하고 있으며, 이는 시장 성장을 촉진할 것으로 예상됩니다. 병원 시설의 증가에 따라 병원에서 시행되는 내시경 검사의 수도 증가하고 있습니다. 미국, 영국, 이탈리아, 스페인, 중국, 인도, 브라질, 남아프리카공화국, 아랍에미리트 등 대부분의 국가에서 병원 수가 증가하고 있습니다. 미국병원협회에 따르면, 2024년 기준 미국에는 6,120개의 병원이 존재합니다. 마찬가지로, 2021년 현재 캐나다에는 1,300개의 병원이 존재합니다. 또한, 유럽연합(EU)에는 약 15,000개의 병원이 존재합니다. 또한, 영국에는 2023년 8월 기준 1,148개의 병원이 확인되었습니다.

또한, 최근 내시경 장비의 시각화 구성요소 및 이미지 강화와 같은 기술 발전으로 인해 조영제 주입 없이도 소화기 병변을 감지할 수 있게 되면서 병원, 진단 센터 및 클리닉에서 이러한 장비에 대한 수요가 증가하고 있습니다. 이는 시장 성장을 촉진하고 있습니다. 예를 들어, 2022년 9월 올림푸스한국은 다양한 내시경 분야의 외과의사 및 의료진의 요구에 부응하는 수술용 시각화 플랫폼 'VISERA ELITE III'를 발표하였습니다. 이 플랫폼은 복강경 담낭 절제술, 복강경 결장 절제술과 같은 최소침습적 수술을 가능하게 하는 다양한 영상 양식을 제공합니다. VISERA ELITE III는 중동 및 아프리카, 유럽, 오세아니아, 아시아, 그리고 일본에서 사용할 수 있습니다.

자주 묻는 질문

  • 경성 내시경 시장 규모는 어떻게 예측되나요?
  • 경성 내시경 시장의 성장 요인은 무엇인가요?
  • 최소침습수술의 장점은 무엇인가요?
  • 경성 내시경 시장에서의 기술 발전은 어떤 영향을 미치고 있나요?
  • 경성 내시경 시장의 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 경성 내시경 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상부 시장 전망
    • 관련 시장 전망
  • 시장 역학
  • 세계의 경성 내시경 : 시장 분석 툴
    • 업계 분석 : Porter's Five Forces
    • PESTLE 분석
  • 사례 연구 분석
  • 기술 동향
  • 복강경 재처리 비용 분석
  • 로봇 보조 수술의 경성 복강경 사용 상황 개요
  • 형광 이미징에 관한 인사이트
  • 가격 분석

제4장 세계의 경성 내시경 시장 부문 분석 : 제품별, 2021-2033년(단위 : 백만 달러)(시술건수, 단위 : 천건, 2021-2033년)(판매량, 단위 : 천대, 2021-2033년)

  • 정의와 범위
  • 제품별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 제품별, 2021-2033년
  • 경성 복강경
  • 부인과용 내시경
  • 소화기 내시경
  • 기관지경
  • 요관경
  • 후두경
  • 이경
  • 방광경
  • 비인두경
  • 관절경
  • 비경
  • 신경 내시경
  • 자궁경

제5장 세계의 경성 내시경 시장 부문 분석 : 시야각별, 2021-2033년

  • 정의와 범위
  • 시야각별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 시야각별, 2021-2033년
  • 30°
  • 45°
  • 기타(70°, 90°, 120° 이상)

제6장 세계의 경성 내시경 시장 부문 분석 : 제품 치수별, 2021-2033년

  • 정의와 범위
  • 제품 치수별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 제품 치수별, 2021-2033년
  • 2mm 미만
  • 2-3.9mm
  • 4-5.9mm
  • 6mm 이상

제7장 세계의 경성 내시경 시장 부문 분석 : 제품 길이별, 2021-2033년

  • 정의와 범위
  • 제품 길이별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 제품 길이별, 2021-2033년
  • 단축 스코프(20cm 미만)
  • 중장 스코프(20-30 cm)[오토클레이브 멸균 가능]
  • 표준/장축 스코프(30-35 cm)
  • 초장축 스코프(35 cm초)[드레이프식(멸균 시스 탑재)]

제8장 세계의 경성 내시경 시장 부문 분석 : 외과 센터 규모별, 2021-2033년

  • 정의와 범위
  • 외과 센터 규모별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 외과 센터 규모별, 2021-2033년
  • 소규모(1-99병상)
  • 중규모(100-299병상)
  • 대규모(300병상 이상)

제9장 세계의 경성 내시경 시장 부문 분석 : 외과 센터 소재지별, 2021-2033년

  • 정의와 범위
  • 외과 센터 소재지별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 외과 센터 소재지별, 2021-2033년
  • 대도시권
  • 교외
  • 지방

제10장 세계의 경성 내시경 시장 부문 분석 : 최종 용도별, 2021-2033년

  • 정의와 범위
  • 최종 용도별 시장 점유율 분석, 2024년·2033년
  • 세계의 경성 내시경 시장 : 최종 용도별, 2021-2033년
  • 병원
  • 외래 시설
  • 대학병원

제11장 경성 내시경 시장 부문 분석 : 지역별, 2021-2033년(시술건수, 단위 : 천건, 2021-2033년)(판매대수, 단위 : 천대, 2021-2033년)

  • 지역별 시장 점유율 분석, 2024년·2033년
  • 지역별 시장 대시보드
  • 지역별 시장 개요
  • 지역별 경성 내시경 시장 점유율, 2024년·2033년 :
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제12장 경쟁 구도

  • 주요 시장 진입 기업별 최근의 발전과 영향 분석
  • 기업 분류
  • 기업별 시장 점유율 분석
  • 기업 레벨 매출·대수 추정
  • 브랜드/모델 사용 상황 : 최종 용도별, 시술 유형별, 지역별
  • 기업 개요
    • Olympus Corporation
    • Arthrex, Inc.
    • Karl Storz GmbH & Co. KG
    • Stryker Corporation
    • Smith+Nephew
    • Richard Wolf GmbH
    • Medtronic Plc
    • B. Braun Melsungen AG
    • CONMED Corporation
KSM

Rigid Endoscopes Market Summary

The global rigid endoscopes market size was estimated at USD 7.31 billion in 2024 and is projected to reach USD 11.11 billion by 2033, growing at a CAGR of 4.74% from 2025 to 2033. The increasing prevalence of cancer and cancer-related mortality globally is one of the factors expected to drive the market.

For instance, according to the Cancer Progress Report 2023 released by the American Cancer Society, in 2023, around 1,958,310 new cancer cases were diagnosed in the U.S., and 609,820 individuals succumbed to it. Projections indicate that by 2040, the number of new cancer cases could reach 2.3 million. As the prevalence of cancer rises globally, there is a growing need for effective diagnostic and treatment procedures. Endoscopes play a crucial role in offering minimally invasive options to accurately diagnose, stage, and treat various forms of cancer.

The increasing prevalence of cancer and cancer-related mortality globally is one of the factors expected to drive the market. For instance, according to the Cancer Progress Report 2023 released by the American Cancer Society, in 2023, around 1,958,310 new cancer cases were diagnosed in the U.S., and 609,820 individuals succumbed to it. Projections indicate that by 2040, the number of new cancer cases could reach 2.3 million. As the prevalence of cancer rises globally, there is a growing need for effective diagnostic and treatment procedures. Endoscopes play a crucial role in offering minimally invasive options to accurately diagnose, stage, and treat various forms of cancer.

Furthermore, endoscopic procedures, such as Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP), are valuable in detecting & assessing cancer in the gastrointestinal tract, lung, and other areas. These procedures allow for precise visualization of internal tissues, biopsy collection, and even removing precancerous growths or early-stage tumors without open surgery. This improves patient outcomes and significantly reduces recovery times & the risk of complications associated with invasive surgical procedures.

Minimally invasive or keyhole surgeries, utilizing small incisions for the diagnosis and treatment of various conditions, are gaining widespread acceptance globally. Surgeons are increasingly favoring robotic & endoscopic surgeries over conventional open surgeries due to the numerous benefits they offer.

Benefits of Minimally Invasive Surgeries

  • Reduced Postoperative Complications: Minimally invasive surgeries significantly lower the risk of postoperative complications compared to traditional open surgeries. The smaller incisions reduce the chances of infection and other surgical complications.
  • Shorter Hospital Stay and Recovery Time: Patients undergoing minimally invasive surgeries typically experience shorter hospital stays and faster recovery times. This enhances patient comfort and reduces the burden on healthcare facilities.
  • Decreased Blood Loss: These surgeries result in less blood loss during procedures, which is crucial for patient safety and recovery.
  • Economic Viability: Minimally invasive surgeries are often more cost-effective than open surgeries. The shorter hospital stays and quicker recoveries reduce overall healthcare costs, making these procedures economically viable alternatives.

The rigid endoscopes market has witnessed a significant surge in FDA approvals and the launch of new products. This is due to the advancements in medical technology and an increasing demand for minimally invasive procedures. Moreover, innovations in imaging technology are facilitating the trend of new product launches, enhancing the precision & effectiveness of diagnostic and therapeutic procedures. The launch of new products is expanding the range of options available to healthcare providers, improving patient outcomes, and promoting competitive dynamics in the market. Hence, manufacturers are intensifying their R&D efforts to stay ahead in this rapidly evolving landscape.

These advancements highlight a significant shift in the market, with a growing number of FDA approvals and product launches improving patient safety and driving market growth. The growing number of healthcare centers, such as hospitals, oncology specialty clinics, and cancer centers, is increasing the need for rigid endoscopes, which is expected to drive market growth. The number of endoscopies being performed in hospitals is growing with the increase in hospital facilities. The number of hospitals is increasing in most countries, including the U.S., the UK, Italy, Spain, China, India, Brazil, South Africa, and the UAE. According to American Hospital Association, there are 6,120 hospitals in the U.S. in 2024. Similarly, in 2021, there were 1,300 hospitals in Canada. The European Union has around 15,000 hospitals. Moreover, the UK has 1148 hospitals as of August 2023.

In addition, recent technological advancements in endoscopy devices, such as visualization components and imaging enhancement, which enabled the detection of gastrointestinal lesions without requiring dye injection, have increased demand for these devices in hospitals, diagnostic centers, and clinics, thereby driving market growth. For instance, in September 2022, Olympus Corporation introduced VISERA ELITE III, a surgical visualization platform catering to the needs of surgeons and healthcare practitioners across various endoscopic disciplines. This platform offers multiple imaging modalities and enables minimally invasive procedures, such as laparoscopic cholecystectomy & laparoscopic colectomy. VISERA ELITE III is available in MEA, Europe, Oceania, Asia, and Japan.

Global Rigid Endoscopes Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global rigid endoscopes market report based on product, angle of view, product dimension, product length, surgical center size, surgical center location, end use, and region:

  • Product Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousands, 2021 - 2033) (Unit Volume, In Thousand Units, 2021 - 2033)
  • Rigid Laparoscopes
  • Gynecology Endoscopes
  • Gastrointestinal Endoscopes
    • Colonoscope
    • Gastroscope (Upper GI Endoscope)
    • Duodenoscope
    • Enteroscope
    • Sigmoidoscope
  • Bronchoscopes
  • Ureteroscopes
  • Laryngoscopes
  • Otoscopes
  • Cystoscopes
  • Nasopharyngoscopes
  • Arthroscopes
  • Rhinoscopes
  • Neuroendoscopes
  • Hysteroscopes
  • Angle of View Outlook (Revenue USD Million, 2021 - 2033)
  • 30°
  • 45°
  • Others (70°, 90°, 120°+)
  • Product Dimension Outlook (Revenue USD Million, 2021 - 2033)
  • <2 mm
  • 2-3.9 mm
  • 4-5.9 mm
  • >=6 mm
  • Product Length Outlook (Revenue USD Million, 2021 - 2033)
  • Short Length Scopes (< 20 cm)
  • Medium Length Scopes (20-30 cm) [Autoclavable]
  • Standard/Long Length Scopes (30-35 cm)
  • Extra-Long Scopes (> 35 cm) [Draped (Sterile Sheathed)]
  • Surgical Center Size Outlook (Revenue USD Million, 2021 - 2033)
  • Small (1-99 beds)
  • Medium (100-299 beds)
  • Large (300+ beds)
  • Surgical Center Location Outlook (Revenue USD Million, 2021 - 2033)
  • Metropolitan
  • Suburban
  • Rural
  • End Use Outlook (Revenue USD Million, 2021 - 2033)
  • Hospitals
  • Outpatient Facilities
    • Ambulatory Surgical Centers
    • Specialty Surgical Centers
  • Academic Hospitals
  • Regional Outlook (Revenue, USD Million, 2021 - 2033) (Procedure Volume, In Thousands, 2021 - 2033) (Unit Volume, In Thousand Units, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook Revenue (USD Million)
  • 2.2. Market Outlook Procedure Volume (Thousands)
  • 2.3. Market Outlook Unit Volume (Thousands)
  • 2.4. Segment Outlook
    • 2.4.1. Product outlook
    • 2.4.2. Angle of view outlook
    • 2.4.3. Product dimension outlook
    • 2.4.4. Product length outlook
    • 2.4.5. Surgical center size outlook
    • 2.4.6. Surgical center location outlook
    • 2.4.7. End use outlook
    • 2.4.8. Regional outlook
  • 2.5. Competitive Insights

Chapter 3. Global Rigid Endoscopes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing Prevalence of Cancer and Cancer-Related Mortality Globally
      • 3.2.1.2. Rising Number of Product Approvals and Launches
      • 3.2.1.3. Increase In Preference for Minimally Invasive or Keyhole Surgeries
      • 3.2.1.4. Increase In the Number of Healthcare Centers and Product Innovation In Endoscopy Field
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising Prevalence Of Noscomial Infection
      • 3.2.2.2. Lack Of Gastroenterologists In Underdeveloped Countries
  • 3.3. Global Rigid Endoscopes: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Case Study Analysis
  • 3.5. Technology Landscape
  • 3.6. Analysis of Reprocessing Costs of Laparoscopes
  • 3.7. Overview of Rigid Laparoscope Usage in Robotic Assisted Surgery
  • 3.8. Fluorescence Imaging Insights
  • 3.9. Pricing Analysis

Chapter 4. Global Rigid Endoscopes Market Segment Analysis, By Product, 2021 - 2033 (USD Million) (Procedure Volume, In Thousands, 2021 - 2033) (Unit Volume, In Thousand Units, 2021 - 2033)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Rigid Endoscopes Market, by Product, 2021 to 2033
  • 4.5. Rigid Laparoscopes
    • 4.5.1. Rigid laparoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2. Rigid laparoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.5.3. Rigid laparoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.6. Gynecology Endoscopes
    • 4.6.1. Gynecology endoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. Gynecology endoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.6.3. Gynecology endoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.7. Gastrointestinal Endoscopes
    • 4.7.1. Gastrointestinal endoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.2. Gastrointestinal endoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.7.3. Gastrointestinal endoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.7.4. Colonoscope
      • 4.7.4.1. Colonoscope market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.4.2. Colonoscope procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
      • 4.7.4.3. Colonoscope unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.7.5. Gastroscope (Upper GI Endoscope)
      • 4.7.5.1. Gastroscope (Upper GI Endoscope) market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.5.2. Gastroscope (Upper GI Endoscope) procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
      • 4.7.5.3. Gastroscope (Upper GI Endoscope) unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.7.6. Duodenoscope
      • 4.7.6.1. Duodenoscope market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.6.2. Duodenoscope procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
      • 4.7.6.3. Duodenoscope unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.7.7. Enteroscope
      • 4.7.7.1. Enteroscope market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.7.2. Enteroscope procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
      • 4.7.7.3. Enteroscope unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.7.8. Sigmoidoscope
      • 4.7.8.1. Sigmoidoscope market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.8.2. Sigmoidoscope procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
      • 4.7.8.3. Sigmoidoscope unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.8. Bronchoscopes
    • 4.8.1. Bronchoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.2. Bronchoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.8.3. Bronchoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.9. Ureteroscopes
    • 4.9.1. Ureteroscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.9.2. Ureteroscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.9.3. Ureteroscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.10. Laryngoscopes
    • 4.10.1. Laryngoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.10.2. Laryngoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.10.3. Laryngoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.11. Otoscopes
    • 4.11.1. Otoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.11.2. Otoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.11.3. Otoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.12. Cystoscopes
    • 4.12.1. Cystoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.12.2. Cystoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.12.3. Cystoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.13. Nasopharyngoscopes
    • 4.13.1. Nasopharyngoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.13.2. Nasopharyngoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.13.3. Nasopharyngoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.14. Arthroscopes
    • 4.14.1. Arthroscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.14.2. Arthroscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.14.3. Arthroscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.15. Rhinoscopes
    • 4.15.1. Rhinoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.15.2. Rhinoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.15.3. Rhinoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.16. Neuroendoscopes
    • 4.16.1. Neuroendoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.16.2. Neuroendoscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.16.3. Neuroendoscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)
  • 4.17. Hysteroscopes
    • 4.17.1. Hysteroscopes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.17.2. Hysteroscopes procedure volume market estimates and forecasts, 2021 to 2033 (In Thousands)
    • 4.17.3. Hysteroscopes unit volume market estimates and forecasts, 2021 to 2033 (In Thousands)

Chapter 5. Global Rigid Endoscopes Market Segment Analysis, By Angle of View, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Angle of View Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Rigid Endoscopes Market, by Angle of View, 2021 to 2033
  • 5.5. 0°
    • 5.5.1. 0°market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. 30°
    • 5.6.1. 30° market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. 45°
    • 5.7.1. 45° market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Others (70°, 90°, 120°+)
    • 5.8.1. Others (70°, 90°, 120°+) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Rigid Endoscopes Market Segment Analysis, By Product Dimension 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Product Dimension Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Rigid Endoscopes Market, by Product Dimension, 2021 to 2033
  • 6.5. <2 mm
    • 6.5.1. <2 mm market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. 2-3.9 mm
    • 6.6.1. 2-3.9 mm market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. 4-5.9 mm
    • 6.7.1. 4-5.9 mm market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. >=6 mm
    • 6.8.1. >=6 mm market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Global Rigid Endoscopes Market Segment Analysis, By Product Length 2021 - 2033 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. Product Length Market Share Analysis, 2024 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Global Rigid Endoscopes Market, by Product Length, 2021 to 2033
  • 7.5. Short Length Scopes (< 20 cm)
    • 7.5.1. Short length scopes (< 20 cm) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Medium Length Scopes (20-30 cm) [Autoclavable]
    • 7.6.1. Medium length scopes (20-30 cm) [Autoclavable] market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Standard/Long Length Scopes (30-35 cm)
    • 7.7.1. Standard/long length scopes (30-35 cm) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. Extra-Long Scopes (> 35 cm) [Draped (Sterile Sheathed)]
    • 7.8.1. Extra-long scopes (> 35 cm) [Draped (Sterile Sheathed)] market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Global Rigid Endoscopes Market Segment Analysis, By Surgical Center Size, 2021 - 2033 (USD Million)

  • 8.1. Definition and Scope
  • 8.2. Surgical Center Size Market Share Analysis, 2024 & 2033
  • 8.3. Segment Dashboard
  • 8.4. Global Rigid Endoscopes Market, by Surgical Center Size, 2021 to 2033
  • 8.5. Small (1-99 beds)
    • 8.5.1. Small (1-99 beds) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Medium (100-299 beds)
    • 8.6.1. Medium (100-299 beds) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Large (300+ beds)
    • 8.7.1. Large (300+ beds) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Global Rigid Endoscopes Market Segment Analysis, By Surgical Center Location, 2021 - 2033 (USD Million)

  • 9.1. Definition and Scope
  • 9.2. Surgical Center Location Market Share Analysis, 2024 & 2033
  • 9.3. Segment Dashboard
  • 9.4. Global Rigid Endoscopes Market, by Surgical Center Location, 2021 to 2033
  • 9.5. Metropolitan
    • 9.5.1. Metropolitan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6. Suburban
    • 9.6.1. Suburban market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.7. Rural
    • 9.7.1. Rural market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Global Rigid Endoscopes Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 10.1. Definition and Scope
  • 10.2. End Use Market Share Analysis, 2024 & 2033
  • 10.3. Segment Dashboard
  • 10.4. Global Rigid Endoscopes Market, by End Use 2021 to 2033
  • 10.5. Hospitals
    • 10.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
  • 10.6. Outpatient Facilities
    • 10.6.1. Ambulatory surgical centers
      • 10.6.1.1. Ambulatory surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
    • 10.6.2. Specialty surgical centers
      • 10.6.2.1. Specialty surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 10.7. Academic Hospitals
    • 10.7.1. Academic hospitals estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 11. Rigid Endoscopes Market Segment Analysis, By Region, 2021- 2033 (USD Million) (Procedure Volume, In Thousands, 2021 - 2033) (Unit Volume, In Thousand Units, 2021 - 2033)

  • 11.1. Regional Market Share Analysis, 2024 & 2033
  • 11.2. Regional Market Dashboard
  • 11.3. Regional Market Snapshot
  • 11.4. Rigid Endoscopes Market Share by Region, 2024 & 2033:
  • 11.5. North America
    • 11.5.1. North America rigid endoscopes market, 2021 - 2033 (USD Million)
    • 11.5.2. North America rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
    • 11.5.3. North America rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.5.4. U.S.
      • 11.5.4.1. Key Country Dynamics
      • 11.5.4.2. Regulatory Scenario
      • 11.5.4.3. Competitive Scenario
      • 11.5.4.4. U.S. rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.5.4.5. U.S. rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.5.4.6. U.S. rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.5.5. Canada
      • 11.5.5.1. Key Country Dynamics
      • 11.5.5.2. Regulatory Scenario
      • 11.5.5.3. Competitive Scenario
      • 11.5.5.4. Canada rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.5.5.5. Canada rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.5.5.6. Canada rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.5.6. Mexico
      • 11.5.6.1. Key Country Dynamics
      • 11.5.6.2. Regulatory Scenario
      • 11.5.6.3. Competitive Scenario
      • 11.5.6.4. Mexico rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.5.6.5. Mexico rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.5.6.6. Mexico rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
  • 11.6. Europe
    • 11.6.1. Europe rigid endoscopes market, 2021 - 2033 (USD Million)
    • 11.6.2. Europe rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
    • 11.6.3. Europe rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.4. UK
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Regulatory Scenario
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. UK rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.4.5. UK rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.4.6. UK rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.5. Germany
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Regulatory Scenario
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Germany rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.5.5. Germany rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.5.6. Germany rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.6. France
      • 11.6.6.1. Key Country Dynamics
      • 11.6.6.2. Regulatory Scenario
      • 11.6.6.3. Competitive Scenario
      • 11.6.6.4. France rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.6.5. France rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.6.6. France rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.7. Italy
      • 11.6.7.1. Key Country Dynamics
      • 11.6.7.2. Regulatory Scenario
      • 11.6.7.3. Competitive Scenario
      • 11.6.7.4. Italy rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.7.5. Italy rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.7.6. Italy rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.8. Spain
      • 11.6.8.1. Key Country Dynamics
      • 11.6.8.2. Regulatory Scenario
      • 11.6.8.3. Competitive Scenario
      • 11.6.8.4. Spain rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.8.5. Spain rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.8.6. Spain rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.9. Norway
      • 11.6.9.1. Key Country Dynamics
      • 11.6.9.2. Regulatory Scenario
      • 11.6.9.3. Competitive Scenario
      • 11.6.9.4. Norway rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.9.5. Norway rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.9.6. Norway rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.10. Sweden
      • 11.6.10.1. Key Country Dynamics
      • 11.6.10.2. Regulatory Scenario
      • 11.6.10.3. Competitive Scenario
      • 11.6.10.4. Sweden rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.10.5. Sweden rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.10.6. Sweden rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.6.11. Denmark
      • 11.6.11.1. Key Country Dynamics
      • 11.6.11.2. Regulatory Scenario
      • 11.6.11.3. Competitive Scenario
      • 11.6.11.4. Denmark rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.6.11.5. Denmark rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.6.11.6. Denmark rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
  • 11.7. Asia Pacific
    • 11.7.1. Asia Pacific rigid endoscopes market, 2021 - 2033 (USD Million)
    • 11.7.2. Asia Pacific rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
    • 11.7.3. Asia Pacific rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.7.4. Japan
      • 11.7.4.1. Key Country Dynamics
      • 11.7.4.2. Regulatory Scenario
      • 11.7.4.3. Competitive Scenario
      • 11.7.4.4. Japan rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.7.4.5. Japan rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.7.4.6. Japan rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.7.5. China
      • 11.7.5.1. Key Country Dynamics
      • 11.7.5.2. Regulatory Scenario
      • 11.7.5.3. Competitive Scenario
      • 11.7.5.4. China rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.7.5.5. China rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.7.5.6. China rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.7.6. India
      • 11.7.6.1. Key Country Dynamics
      • 11.7.6.2. Regulatory Scenario
      • 11.7.6.3. Competitive Scenario
      • 11.7.6.4. India rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.7.6.5. India rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.7.6.6. India rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.7.7. Australia
      • 11.7.7.1. Key Country Dynamics
      • 11.7.7.2. Regulatory Scenario
      • 11.7.7.3. Competitive Scenario
      • 11.7.7.4. Australia rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.7.7.5. Australia rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.7.7.6. Australia rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.7.8. South Korea
      • 11.7.8.1. Key Country Dynamics
      • 11.7.8.2. Regulatory Scenario
      • 11.7.8.3. Competitive Scenario
      • 11.7.8.4. South Korea rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.7.8.5. South Korea rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.7.8.6. South Korea rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.7.9. Thailand
      • 11.7.9.1. Key Country Dynamics
      • 11.7.9.2. Regulatory Scenario
      • 11.7.9.3. Competitive Scenario
      • 11.7.9.4. Thailand rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.7.9.5. Thailand rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.7.9.6. Thailand rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
  • 11.8. Latin America
    • 11.8.1. Latin America rigid endoscopes market, 2021 - 2033 (USD Million)
    • 11.8.2. Latin America rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
    • 11.8.3. Latin America rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.8.4. Brazil
      • 11.8.4.1. Key Country Dynamics
      • 11.8.4.2. Regulatory Scenario
      • 11.8.4.3. Competitive Scenario
      • 11.8.4.4. Brazil rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.8.4.5. Brazil rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.8.4.6. Brazil rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.8.5. Argentina
      • 11.8.5.1. Key Country Dynamics
      • 11.8.5.2. Regulatory Scenario
      • 11.8.5.3. Competitive Scenario
      • 11.8.5.4. Argentina rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.8.5.5. Argentina rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.8.5.6. Argentina rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
  • 11.9. MEA
    • 11.9.1. MEA rigid endoscopes market, 2021 - 2033 (USD Million)
    • 11.9.2. MEA rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
    • 11.9.3. MEA rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.9.4. South Africa
      • 11.9.4.1. Key Country Dynamics
      • 11.9.4.2. Regulatory Scenario
      • 11.9.4.3. Competitive Scenario
      • 11.9.4.4. South Africa rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.9.4.5. South Africa rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.9.4.6. South Africa rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.9.5. Saudi Arabia
      • 11.9.5.1. Key Country Dynamics
      • 11.9.5.2. Regulatory Scenario
      • 11.9.5.3. Competitive Scenario
      • 11.9.5.4. Saudi Arabia rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.9.5.5. Saudi Arabia rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.9.5.6. Saudi Arabia rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.9.6. UAE
      • 11.9.6.1. Key Country Dynamics
      • 11.9.6.2. Regulatory Scenario
      • 11.9.6.3. Competitive Scenario
      • 11.9.6.4. UAE rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.9.6.5. UAE rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.9.6.6. UAE rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)
    • 11.9.7. Kuwait
      • 11.9.7.1. Key Country Dynamics
      • 11.9.7.2. Regulatory Scenario
      • 11.9.7.3. Competitive Scenario
      • 11.9.7.4. Kuwait rigid endoscopes market, 2021 - 2033 (USD Million)
      • 11.9.7.5. Kuwait rigid endoscopes market by procedure volume, 2021 - 2033 (In Thousands)
      • 11.9.7.6. Kuwait rigid endoscopes market by unit volume, 2021 - 2033 (In Thousands)

Chapter 12. Competitive Landscape

  • 12.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 12.2. Company Categorization
  • 12.3. Company Market Share Analysis
  • 12.4. Estimated Company Level Revenue and Unit Volume
  • 12.5. Brand/Model Usage By End Use, Procedure Type, And Geography
  • 12.6. Company Profiles
    • 12.6.1. Olympus Corporation
      • 12.6.1.1. Company overview
      • 12.6.1.2. Financial performance
      • 12.6.1.3. Product benchmarking
      • 12.6.1.4. Strategic initiatives
    • 12.6.2. Arthrex, Inc.
      • 12.6.2.1. Company overview
      • 12.6.2.2. Financial performance
      • 12.6.2.3. Product benchmarking
      • 12.6.2.4. Strategic initiatives
    • 12.6.3. Karl Storz GmbH & Co. KG
      • 12.6.3.1. Company overview
      • 12.6.3.2. Financial performance
      • 12.6.3.3. Product benchmarking
      • 12.6.3.4. Strategic initiatives
    • 12.6.4. Stryker Corporation
      • 12.6.4.1. Company overview
      • 12.6.4.2. Financial performance
      • 12.6.4.3. Product benchmarking
      • 12.6.4.4. Strategic initiatives
    • 12.6.5. Smith+Nephew
      • 12.6.5.1. Company overview
      • 12.6.5.2. Financial performance
      • 12.6.5.3. Product benchmarking
      • 12.6.5.4. Strategic initiatives
    • 12.6.6. Richard Wolf GmbH
      • 12.6.6.1. Company overview
      • 12.6.6.2. Financial performance
      • 12.6.6.3. Product benchmarking
      • 12.6.6.4. Strategic initiatives
    • 12.6.7. Medtronic Plc
      • 12.6.7.1. Company overview
      • 12.6.7.2. Financial performance
      • 12.6.7.3. Product benchmarking
      • 12.6.7.4. Strategic initiatives
    • 12.6.8. B. Braun Melsungen AG
      • 12.6.8.1. Company overview
      • 12.6.8.2. Financial performance
      • 12.6.8.3. Product benchmarking
      • 12.6.8.4. Strategic initiatives
    • 12.6.9. CONMED Corporation
      • 12.6.9.1. Company overview
      • 12.6.9.2. Financial performance
      • 12.6.9.3. Product benchmarking
      • 12.6.9.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제